Kangstem Biotech Co (XKRX:217730) Dividends per Share : ₩0.00 (TTM As of Sep. 2024)

View and export this data going back to 2015. Start your Free Trial

What is Kangstem Biotech Co Dividends per Share?

Kangstem Biotech Co's dividends per share for the three months ended in Sep. 2024 was ₩0.00. Its dividends per share for the trailing twelve months (TTM) ended in Sep. 2024 was ₩0.00. Its Dividend Payout Ratio for the three months ended in Sep. 2024 was 0.00. As of today, Kangstem Biotech Co's Dividend Yield % is 0.00%.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Kangstem Biotech Co Dividends per Share Historical Data

The historical data trend for Kangstem Biotech Co's Dividends per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kangstem Biotech Co Dividends per Share Chart

Kangstem Biotech Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dividends per Share

Get a 7-Day Free Trial

Kangstem Biotech Co Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Dividends per Share	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Kangstem Biotech Co's Dividends per Share

For the Biotechnology subindustry, Kangstem Biotech Co's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kangstem Biotech Co's Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Kangstem Biotech Co's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Kangstem Biotech Co's Dividend Yield % falls into.

Kangstem Biotech Co Dividends per Share Calculation

Dividends paid to per common share.

Kangstem Biotech Co (XKRX:217730) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Kangstem Biotech Co's Dividend Payout Ratio for the quarter that ended in Sep. 2024 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Sep. 2024 )	/	EPS without NRI (Q: Sep. 2024 )
	=	0	/	-72.48
	=	N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

Kangstem Biotech Co Dividends per Share Related Terms

Thank you for viewing the detailed overview of Kangstem Biotech Co's Dividends per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Kangstem Biotech Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kangstem Biotech Co Ltd (XKRX:217730) » Definitions » Dividends per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

512 Teheran-ro, Gangnam-gu, 17th Floor, Sinan Building, Seoul, KOR

Website

http://www.kangstem.com

Kangstem Biotech Co Ltd develops technology to isolate the non-hematological system stem cell with conversion and purity from the cord blood and to culture large quantity. Its Furestem therapies include Furestem-AD, Furestem-RA and Furestem-CD. Its businesses include cord blood-derived stem cell therapy business; cord blood-derived stem cell conditioned media business; and stem cell culture media business.

Kangstem Biotech Co Headlines

No Headlines